"In This Episode"
Mike Tomasco discusses the integration of generative AI in biopharmaceutical manufacturing, particularly how it can enhance shop-floor operations and improve efficiency. Mike, a former VP of digitization at Pfizer, emphasizes the potential of AI-driven tools like Katalyze AI to simplify complex tasks for operators by acting as a co-pilot. This technology can predict and suggest optimal actions based on historical data, helping to pre-empt issues and guide newer employees to operate with the expertise of long-time workers.


"Revolutionize Your Biomanufacturing with Katalyze AI"
Experience how Katalyze AI’s platform can transform your operations by enhancing yield, improving traceability, and reducing cycle times across your biopharma processes.

"Here’s What You Can Achieve"
- Up to 8% Yield Increase: Minimize deviations and optimize quality with AI-powered digital twins tailored to your processes.
- 40% Faster Batch Release: Streamline raw material quality control by automating data consolidation and specification checks.
- Save Up to 4 Hours on Investigations: Leverage a unified source of truth for raw material and process data to quickly identify root causes and draft reports.
Get Your Free Demo Today

Curious about how Katalyze AI can elevate your manufacturing operations? Fill out the form, and our team will provide a tailored demonstration to discuss solutions specific to your needs.

"Key Features Include"
- More Than 10+ out-of-the-box Integrations
- Access to Katalyze AI's Large Biologic Models
- Science-Backed Yield and Quality Improvement
Book Your Free Demo Now : https://katalyzeai.com/contactus

From Paper to Prediction: AI's Role in Enhancing Biomanufacturing Operations

"In This Episode"

In this episode, we dive deep into how AI is reshaping the pharmaceutical manufacturing landscape with Harini Gopalakrishnan. From improving operational efficiency to leveraging predictive analytics and generative content, Harini shares her expertise on driving smarter, faster, and more accurate decisions in this critical industry. 

Harini Gopalakrishnan is a seasoned professional with 17+ years of experience at the intersection of life sciences and technology. She has worked across various sectors including consulting, pharma, CRO, and tech, gaining expertise in product innovations, strategic partnerships, and tech interventions. Known for her energy, drive, and entrepreneurial mindset, she excels at creating strategic alliances with organizational leaders to align and support key business initiatives. Harini was the winner of the Gartner Award in 2020 for the "Innovative Use of an Emerging Technology in Pharma and Life Sciences.”


"Revolutionize Your Biomanufacturing with Katalyze AI"

Experience how Katalyze AI’s platform can transform your operations by enhancing yield, improving traceability, and reducing cycle times across your biopharma processes.


"Here’s What You Can Achieve"

Up to 8% Yield Increase: Minimize deviations and optimize quality with AI-powered digital twins tailored to your processes.
40% Faster Batch Release: Streamline raw material quality control by automating data consolidation and specification checks.
Save Up to 4 Hours on Investigations: Leverage a unified source of truth for raw material and process data to quickly identify root causes and draft reports.


"Get Your Free Demo Today"

Curious about how Katalyze AI can elevate your manufacturing operations? Fill out the form, and our team will provide a tailored demonstration to discuss solutions specific to your needs.


"Key Features Include"

- More Than 10+ out-of-the-box Integrations
- Access to Katalyze AI's Large Biologic Models
- Science-Backed Yield and Quality Improvement

Book Your Free Demo Now: https://katalyzeai.com/contactus




Driving Pharma Innovation with AI: A Conversation with Harini Gopalakrishnan

We’re thrilled to welcome  Emmanuel Walckenaer, CEO of Yseop, back to AI Uncovered for a follow-up conversation on the rapid evolution of AI in biopharma. Since his last appearance, the industry has made significant strides in harnessing AI for regulatory submissions, clinical workflows, and medical writing—areas where Yseop is leading the charge in transforming content generation.

In this episode, Tim and Emmanuel revisit the biggest AI breakthroughs of 2024 and explore how the pharmaceutical sector is shifting from skepticism to large-scale adoption. They discuss real-world success stories, the growing impact of federated data sharing, and what companies should prioritize as they plan for 2025 and beyond.

With his unique perspective on SaaS growth, AI regulation, and enterprise adoption, Emmanuel provides invaluable insights for professionals navigating the intersection of AI and life sciences. If you're looking to understand the next wave of AI-driven innovation in pharma, this is an episode you won't want to miss.

Emmanuel Walckenaer - AI’s Real-World Impact on Pharma & What’s Next in 2025

We’re excited to welcome Oeystein Kjoersvik to AI Uncovered. Oeystein leads the Generative AI program within the Quality Assurance team at Merck, where he focuses on developing AI tools and applying a quality-first approach to ensure safe, effective use of AI in GxP-regulated environments.

In this episode, Tim and Oeystein delve into the challenges of adopting AI in regulated settings, the complexity of validating GenAI tools, and the transition from traditional processes to AI-augmented systems. They also explore Oeystein’s work with the IMPALA Consortium and the importance of cross-industry collaboration to identify and scale high-value use cases for Generative AI.

Before his current role, Oeystein served as a Product Owner in Analytics at Merck IT, building analytics platforms and integrating data science across systems. He also contributed as a Machine Learning Subject Matter Expert to TransCelerate’s Intelligent Automation Group, advancing AI applications in pharmacovigilance.

Oeystein brings a rare blend of technical expertise and regulatory insight. He’s passionate about helping teams adopt AI responsibly and transparently—ensuring innovation aligns with quality across the pharmaceutical landscape.

Oeystein Kjoersvik - Auditing AI: Quality, Compliance & the Role of GenAI in Pharma

AI just changed content—again. Here’s what’s next.

Get ahead of the AI curve: see what’s new in content automation, reasoning, and strategy.

AI tools have drastically reshaped how great content gets made. This past year saw a leap in models, reasoning, and speed. But now? We’re entering the era of creative AI teams.

We’ve pulled together a breakdown of:
• New players like DeepSeek shaking up the scene
• How models are now thinking before they write
• What content creation will look like by 2026

You can also read this in an article format on our website: https://iguazu.co.uk/articles/ai-content-advancements?utm_source=Soundcloud&utm_medium=social_media&utm_campaign=ai-catchup-2025&utm_id=promo

AI Content Advancements 2025: Catch Up or Get Left Behind

Learn about the power of AI tools being used to create AI-generated podcasts which can offer engagement and learning benefits.

AI is reshaping podcasting as we know it. Whether generating an audio podcast with Google’s NotebookLM or adding dynamic virtual hosts through Heygen, these tools make podcast creation faster, easier, and more engaging.

Listen to our latest podcast to see how we leveraged AI to produce a podcast about Noxivision. Plus, get a sneak peek at Google Illuminate and other tools that promise to revolutionise your workflow.

Discover how AI can work for you!

You can also read the article here 👉 https://iguazu.co.uk/articles/introducing-ai-generated-podcasts-exploring-the-benefits?utm_source=SoundCloud&utm_medium=social_media&utm_campaign=intro-ai-podcasts&utm_id=promo

Introducing AI-Generated Podcasts: Exploring the Benefits

Discover how interactive, AI-powered eLearning accelerates product uptake, lifts brand recall and keeps ABPI compliance on track. Real-world stats, use-cases and an ROI checklist inside.

Read the text version of this podcast on our articles page >> https://iguazu.co.uk/articles/pharma-elearning-engagement?utm_source=Soundcloud&utm_medium=social_media&utm_campaign=not-boring-elearning&utm_id=article

Do not make it boring! Smarter eLearning Strategies for Pharma Brand Managers

Discover how Iguazu's AI video tools, like Sora and Midjourney, are revolutionising pharma MOA storytelling with unparalleled realism, seamless transitions, and guaranteed compliance.

Read the text version of this podcast on our articles page >> https://iguazu.co.uk/articles/new-ai-video-tools-for-moa-storytelling?utm_source=soundcloud&utm_medium=email&utm_campaign=noxivision-9-moa&utm_id=article

Part 9: Noxivision - How the New Wave of AI Video Tools Transforms MOA Storytelling

Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.

The digital healthcare marketing agency. Sharing podcasts & articles from our experts.
⭐️ Iguazu: https://iguazu.co.uk/ 
📖 Articles: https://iguazu.co.uk/articles
ℹ️ What we do: https://iguazu.co.uk/our-services
✉️ Get in touch: https://iguazu.co.uk/contact-us

New tracks tagged #AIinPharma